{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T17:10:09Z","timestamp":1747847409401,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10020-z","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T16:01:50Z","timestamp":1728489710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Facial cutaneous tuberculosis infected by non-tuberculous mycobacteria"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2939-1730","authenticated-orcid":false,"given":"Xu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CaiFen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"issue":"7","key":"10020_CR1","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.62347\/MAJY5046","volume":"16","author":"WH Lin","year":"2024","unstructured":"Lin WH, Yao C, Mei L, Wang DP, Bao XD, Liu SS. Screening, epidemic trends and drug sensitivity analysis of nontuberculous mycobacteria in a local area of China. AM J TRANSL RES. 2024;16(7):3298\u2013305.","journal-title":"AM J TRANSL RES"},{"issue":"9","key":"10020_CR2","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3201\/eid3009.240095","volume":"30","author":"VN Dahl","year":"2024","unstructured":"Dahl VN, Pedersen AA, Norman A, Rasmussen EM, van Ingen J, Andersen AB, Wejse CM, Lillebaek T. Clinical significance, species distribution, and temporal trends of Nontuberculous Mycobacteria, Denmark, 1991\u20132022. EMERG INFECT DIS. 2024;30(9):1755\u201362.","journal-title":"EMERG INFECT DIS"},{"issue":"15","key":"10020_CR3","doi-asserted-by":"publisher","first-page":"e35311","DOI":"10.1016\/j.heliyon.2024.e35311","volume":"10","author":"N Xu","year":"2024","unstructured":"Xu N, Li L, Wu S. Epidemiology and laboratory detection of non-tuberculous mycobacteria. HELIYON. 2024;10(15):e35311.","journal-title":"HELIYON"},{"key":"10020_CR4","doi-asserted-by":"crossref","unstructured":"Kozi\u0144ska M, Augustynowicz-Kope\u0107 E, Gamian A, Chudzik A, Pa\u015bciak M, Zdziarski P. Cutaneous and Pulmonary Tuberculosis-Diagnostic and Therapeutic Difficulties in a Patient with Autoimmunity. PATHOGENS 2023, 12(2).","DOI":"10.3390\/pathogens12020331"},{"key":"10020_CR5","doi-asserted-by":"crossref","unstructured":"Kim J, Hoon RJ, Jang J, Jang H, Lim JB. Comparative assessment of trough and peak levels and AUC24 for amikacin in nontuberculous mycobacterial infection. CLIN CHIM ACTA 2024:119963.","DOI":"10.1016\/j.cca.2024.119963"},{"key":"10020_CR6","doi-asserted-by":"crossref","unstructured":"Sreekumar A, Kumar A, Biswas R, Biswas L. Emerging and alternative strategies for the treatment of nontuberculous mycobacterial infections. EXPERT REV ANTI-INFE 2024:1\u201319.","DOI":"10.1080\/14787210.2024.2395003"},{"issue":"6","key":"10020_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jaad.2021.12.064","volume":"89","author":"S Kaul","year":"2023","unstructured":"Kaul S, Jakhar D, Mehta S, Singal A. Cutaneous tuberculosis. Part II: complications, diagnostic workup, histopathologic features, and treatment. J AM ACAD DERMATOL. 2023;89(6):1107\u201319.","journal-title":"J AM ACAD DERMATOL"},{"key":"10020_CR8","doi-asserted-by":"publisher","first-page":"942073","DOI":"10.3389\/fcimb.2022.942073","volume":"12","author":"M Kong","year":"2022","unstructured":"Kong M, Li W, Kong Q, Dong H, Han A, Jiang L. Application of metagenomic next-generation sequencing in cutaneous tuberculosis. FRONT CELL INFECT MI. 2022;12:942073.","journal-title":"FRONT CELL INFECT MI"},{"issue":"1","key":"10020_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/rheumatology\/kem307","volume":"47","author":"R Hesselstrand","year":"2008","unstructured":"Hesselstrand R, Scheja A, Wildt M, Akesson A. High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease. Rheumatology. 2008;47(1):84\u20137.","journal-title":"Rheumatology"},{"issue":"4","key":"10020_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40477-019-00379-0","volume":"22","author":"O Catalano","year":"2019","unstructured":"Catalano O, Rold\u00e1n FA, Varelli C, Bard R, Corvino A, Wortsman X. Skin cancer: findings and role of high-resolution ultrasound. J ULTRASOUND. 2019;22(4):423\u201331.","journal-title":"J ULTRASOUND"},{"issue":"9","key":"10020_CR11","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00247-022-05434-3","volume":"52","author":"C Garcia","year":"2022","unstructured":"Garcia C, Wortsman X, Bazaes-Nu\u00f1ez D, Pelizzari M, Gonzalez S, Cossio ML, De Barbieri F. Skin sonography in children: a review. PEDIATR RADIOL. 2022;52(9):1687\u2013705.","journal-title":"PEDIATR RADIOL"},{"key":"10020_CR12","doi-asserted-by":"publisher","first-page":"1451602","DOI":"10.3389\/fcimb.2024.1451602","volume":"14","author":"XY Wang","year":"2024","unstructured":"Wang XY, Jia QN, Li J, Zheng HY. Investigating cutaneous tuberculosis and nontuberculous mycobacterial infections a Department of Dermatology, Beijing, China: a comprehensive clinicopathological analysis. FRONT CELL INFECT MI. 2024;14:1451602.","journal-title":"FRONT CELL INFECT MI"},{"issue":"8","key":"10020_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.5588\/ijtldopen.24.0238","volume":"1","author":"D Deshpande","year":"2024","unstructured":"Deshpande D, Magombedze G, Srivastava S, Gumbo T. Antibacterial action of penicillin against Mycobacterium avium complex. IJTLD Open. 2024;1(8):362\u20138.","journal-title":"IJTLD Open"},{"issue":"8","key":"10020_CR14","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s40121-024-01015-z","volume":"13","author":"K Morimoto","year":"2024","unstructured":"Morimoto K, Gallagher JR, Wagner D, Griffith DE, van Ingen J. Real-world patients\u2019 diagnosis-to-treatment journey with Nontuberculous Mycobacterial Pulmonary Disease: a cross-sectional survey. INFECT DIS THER. 2024;13(8):1907\u201320.","journal-title":"INFECT DIS THER"},{"key":"10020_CR15","doi-asserted-by":"publisher","first-page":"1394220","DOI":"10.3389\/fmicb.2024.1394220","volume":"15","author":"LE Conyers","year":"2024","unstructured":"Conyers LE, Saunders BM. Treatment for non-tuberculous mycobacteria: challenges and prospects. FRONT MICROBIOL. 2024;15:1394220.","journal-title":"FRONT MICROBIOL"},{"key":"10020_CR16","doi-asserted-by":"crossref","unstructured":"van Staden D, Haynes RK, Viljoen JM. Adapting clofazimine for treatment of cutaneous tuberculosis by using self-double-emulsifying drug Delivery systems. ANTIBIOTICS-BASEL 2022, 11(6).","DOI":"10.3390\/antibiotics11060806"},{"key":"10020_CR17","doi-asserted-by":"crossref","unstructured":"Metersky ML, Fraulino D, Monday L, Chopra T. Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review. POSTGRAD MED 2024:1\u201312.","DOI":"10.1080\/00325481.2024.2401766"},{"issue":"2","key":"10020_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7705\/biomedica.7197","volume":"44","author":"C Llerena","year":"2024","unstructured":"Llerena C, Valbuena YA, Zabaleta AP, Garc\u00eda AN. Prevalence of resistance to macrolides and aminoglycosides in Mycobacterium avium, M. Abscessus, and M. Chelonae identified in the Laboratorio Nacional De Referencia of Colombia from 2018 to 2022. BIOMEDICA. 2024;44(2):182\u201390.","journal-title":"BIOMEDICA"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10020-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T16:01:53Z","timestamp":1728489713000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10020"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10020-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was designed and conducted following the Helsinki Declaration and approved by the Ethics Committee of the Hangzhou Red Cross Hospital. An informed consent was signed by the patient as part of the hospital\u2019s routine activity. The manuscript has been reviewed and approved by all named authors. The criteria for authorship have been met and each author believes that the manuscript represents honest work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The patient gave consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Written informed consent has been obtained from the patient\u2019s legal guardian to publish this report and any accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1131"}}